Effect of Meat and Egg on TMAO in Plasma and Urine in Subjects with and Metabolic Subjects
Trimethylamine-N-oxide After Animal Food - Effects of Gut Microbiota in Subjects with and Without Metabolic Syndrome
1 other identifier
interventional
33
1 country
1
Brief Summary
The purpose of this clinical trial is to investigate in subjects with and without metabolic syndrome how meals of choline- and carnitine-rich foods (eggs and meat) affect the trimethylamine-N-oxide (TMAO) concentration in blood and urine in relation to the gut microbiota composition. In response to the subjects´ gut microbiota, the concentrations of TMAO in the plasma and urine of subjects with and without metabolic syndrome (MetS) after ingesting choline- and carnitine-rich foods will be compared. On two occasions, participants will receive after overnight fasting meatballs (170 g) or three hard-boiled eggs. Blood will be collected before ingestion and over 6 hours after test food consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2024
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedOctober 28, 2024
October 1, 2024
3.2 years
October 7, 2024
October 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
TMAO and related metabolite concentrations (micromole per litre) in plasma
TMAO and related metabolites (trimethylamine, betaine, choline, L-carnitine, and acetyl-L-carnitine) were analyzed by UPLC-MRM-MS in plasma samples collected before ingestion of test food and after ingestion at 30, 60, 120, 240, and 360 minutes.
Metabolite concentrations in plasma samples collected before ingestion of test food and after ingestion at 30, 60, 120, 240, and 360 minutes are used for calculation the incremental area under the curve.
TMAO and related metabolite concentrations (micromole per litre) in urine
TMAO and related metabolites (trimethylamine, betaine, choline, L-carnitine, and acetyl-L-carnitine) were analyzed by UPLC-MRM-MS in a composite urine sample collected during 6 hours post-dose.
Post-dose sample over a 6-hours period.
Secondary Outcomes (4)
Gut microbiota composition
The day before the first intervention day.
Blood glucose and glycated hemoglobin
At screening (before intervention).
Plasma lipid profile
At screening (before intervention).
Body mass index (BMI)
At screening (before intervention).
Study Arms (2)
Subjects with MetS
ACTIVE COMPARATORSubjects with a minimum of three criteria according to NCEP-ATP III. Subjects were administered in randomized order after overnight fasting a test food. Test days were on two separate occasions around 2 weeks apart. Egg intervention: three hard-boiled eggs. Meatball intervention: 170 g meatballs.
Subjects without MetS
ACTIVE COMPARATORSubjects, apparently healthy, with normal BMI, blood pressure, waist circumference (see inclusion criteria). Subjects were administered in randomized order after overnight fasting a test food. Test days were on two separate occasions around 2 weeks apart. Egg intervention: three hard-boiled eggs. Meatball intervention: 170 g meatballs.
Interventions
Oral administration of three hard-boiled eggs to be ingested within 15 minutes on one occasion.
Oral intervention with 170 g meatballs to be ingested within 15 minutes on one occasion.
Eligibility Criteria
You may qualify if:
- Age = 18-75y
- Plasma creatinine value within the age-related reference range
- No history of acute or chronic diseases (e.g. diabetes or bowel disease)
- No use of vitamin or mineral supplements, no medication with antibiotics 2 months before recruitment and during the study
- Non-smoker
- Not consuming a special diet (vegetarian)
- No pregnancy, planned conception, or lactation
- No participation in another study.
- Normal BMI (18.6 to 29.0 kg / m 2 )
- Blood counts within reference ranges
- Normal ranges for liver enzymes (P-ALAT, P-AST, P-ALP), blood status, plasma triglycerides, plasma HDL cholesterol, plasma cholesterol, plasma glucose
- A minimum of three of the following criteria according the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III):
- Waist size \> 102 cm in men, \> 88 cm in women
- Fasting plasma glucose ≥ 5.6 mmol /l
- Triglycerides \> 1.7 mmol / l or treatment
- +2 more criteria
You may not qualify if:
- Smoker
- Pregnancy, planned conception, or lactation
- Medical treatment with antibiotics 2 months before recruitment and during the study
- Use of dietary supplements 2 weeks before and during the study
- Use of probiotics 2 months before and during the study
- Following a special diet (eg vegan, vegetarian, weight loss)
- Participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linnaeus Universitylead
- Umeå Universitycollaborator
Study Sites (1)
Faculty of Health and Life Sciences, Linnaeus University
Kalmar, 392 31, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed E Hefni, Assoc Prof
Linnaeus University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 28, 2024
Study Start
February 7, 2020
Primary Completion
May 5, 2023
Study Completion
May 5, 2024
Last Updated
October 28, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual data as all data will be presented in the main article through tables and figures or in the supplementary material as mean ± standard deviation. However, individual data will be made available upon reasonable request.